CareDx, Inc. (CDNA)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Total revenue | 86,679 | 84,685 | 82,883 | 92,274 |
| Restructuring costs | - | - | - | 68 |
| Cost of testing services, product, digital, and other | - | 28,415 | 27,572 | 27,946 |
| Sales and marketing | 24,279 | 22,991 | 19,802 | 21,002 |
| Research and development | 16,830 | 18,524 | 17,486 | 19,678 |
| General and administrative | 27,683 | 22,769 | 28,515 | 27,678 |
| Litigation settlement expense | -350 | -5,360 | - | - |
| Cost of testing services, product, patient and digital solutions-Service | 15,406 | - | - | - |
| Cost of testing services, product, patient and digital solutions-Product | 4,981 | - | - | - |
| Cost of testing services, product, patient and digital solutions-Patient And Digital Solutions | 8,271 | - | - | - |
| Total operating expenses | 97,800 | 98,059 | 93,375 | 96,372 |
| Loss from operations | -11,121 | -13,374 | -10,492 | -4,098 |
| Change in estimated fair value of common stock warrant liability | - | - | - | - |
| Other income (expense), net | 72 | 295 | 283 | -100 |
| Interest income, net | 2,364 | 2,784 | 3,001 | 2,826 |
| Total other income | 2,436 | 3,079 | 3,284 | 2,726 |
| Loss before income taxes | -8,685 | -10,295 | -7,208 | -1,372 |
| Income tax benefit (expense) | -117 | 58 | 200 | 22 |
| Net loss | -8,568 | -10,353 | -7,408 | -1,394 |
| Basic (in shares) | 54,304,754 | 55,262,459 | 52,903,338 | 52,195,620 |
| Basic (in usd per share) | -0.16 | -0.19 | -0.14 | -0.03 |
| Diluted (in shares) | 54,304,754 | 55,262,459 | 52,903,338 | 52,195,620 |
| Diluted (in usd per share) | -0.16 | -0.19 | -0.14 | -0.03 |